This 2-hour online course offers a streamlined alternative to traditional 8-hour buprenorphine training, providing a fast and efficient way to equip prescribers with the knowledge needed to effectively treat patients with opioid use disorder.

This 45-minute, on-demand session from the ASAM 2022 Review Course provides an overview of the history of opioid use and opioid regulation, explores the neurobiology and pharmacology of opioids, and reviews treatment options for opioid use disorder and opioid withdrawal.

This 1-hour, on-demand session from the ASAM 53rd Annual Conference describes advantages and barriers to utilizing extended-release buprenorphine rather than sublingual formulations in patients with opioid use disorder.

This 1-hour, on-demand session from the ASAM 53rd Annual Conference provides the knowledge needed to interpret both UDS and confirmatory urine drug testing of opioids.

This 1-hour, on-demand session from the ASAM 53rd Annual Conference discusses the safe and effective use of naloxone in opioid overdose and subsequent management to improve connections to care for opioid use disorder.

This 16-hour, on-demand course is the essential primer for physicians preparing for the addiction medicine examination and also serves to increase other healthcare professionals' knowledge of addiction.

This one-hour, on-demand, journal article-based activity presents a scoping review on the efficacy of GLP-1 agonists in the treatment of patients with substance use disorder. While there is interest in exploring the use of GLP-1 agonists in the treatment of SUD, evidence for safety and efficacy of GLP-1 agonists in humans is limited. The results of this scoping review are mixed, and the authors call for further research to determine the efficacy of GLP-1 agonists in treating SUD.

This one-hour, on-demand, journal article-based activity presents a scoping review on the prevalence of high-potency synthetic opioids (HPSOs) in the nonmedical drug supply and their interactions with medications for opioid use disorder (MOUDs). The interactions between HPSOs and MOUDs are not yet well understood. This review examines the relationship between HPSO exposure and patient outcomes when using common MOUD treatment protocols. It also discusses the implications for clinical practice and suggests directions for future research based on the current research on patient populations impacted by HPSOs.

This one-hour, on-demand, journal article-based activity presents original research analyzing readmission data for among patients with surgically managed drug use associated-infective endocarditis. It explores the efficacy of exposure to an addiction consult team to address and mitigate factors contributing to readmissions.

This one-hour, on-demand, journal article-based activity presents research on a pilot of a rapid methadone initiation protocol for hospitalized patients with opioid use disorder (OUD).

This one-hour, on-demand, journal article-based activity presents a scoping review of the existing literature on the effectiveness and safety of high-dose buprenorphine initiation across fifteen studies across a range of health care settings.

This 2-hour online course offers a streamlined alternative to traditional 8-hour buprenorphine training, providing a fast and efficient way to equip prescribers with the knowledge needed to effectively treat patients with opioid use disorder.

This 50-minute, on-demand session from the ASAM 2024 Review Course provides an overview of the history of opioid use and opioid regulation, explores the neurobiology and pharmacology of opioids, and reviews treatment options for opioid use disorder and opioid withdrawal.

This 1.5-hour, on-demand course is part of an online case-based learning collaborative series focused on treating opioid use disorder.

This 1-hour, online module focuses on health disparities in substance use and the causes therein, with a special emphasis on what you can do in your practice to utilize a socioecological approach to address racial inequities in the addiction medicine field.